
DOJ investigating UnitedHealth over Medicare Advantage billing: Report
By Drew Pittock (Digital Producer)
- The DOJ has launched a civil fraud investigation into UnitedHealthcare over its billing practices in the Medicare Advantage program, according to the Wall Street Journal. The investigation focuses on whether the healthcare giant artificially inflated patient diagnoses to increase its monthly payments from the government.
- In a statement, UnitedHealth Group called reporting by the Journal “outrageous and false” and accused the outlet of reporting “misinformation” about its partnership with Medicare Advantage.
- This investigation is just the latest in a series of scandals to have dogged the healthcare giant since last year.
Full Story
UnitedHealthcare is currently under investigation by the U.S. Department of Justice (DOJ), according to a recent report from the Wall Street Journal. The government has launched a civil fraud investigation, looking at whether the embattled healthcare giant is illegally inflating its monthly payments received by the Medicare Advantage program, using patient diagnoses.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn moreBias Summary
- The U.S. Department of Justice has initiated a civil fraud investigation into UnitedHealth Group's Medicare billing practices, according to The Wall Street Journal.
- UnitedHealth Group's shares fell by 12% after the fraud investigation was reported.
- Physicians have indicated that UnitedHealth encouraged misleading diagnoses through training and software, raising concerns about the accuracy of medical billing.
- Doctors have claimed that UnitedHealth trained them to document profit-generating diagnoses, some of which were deemed questionable.
- No summary available because of a lack of coverage.
- The Department of Justice has started a civil fraud investigation into UnitedHealth's Medicare billing practices, according to the Wall Street Journal.
- UnitedHealth's shares dropped nearly 12% following the news, reflecting investor concerns about how the probe may affect profitability.
- The investigation focuses on how UnitedHealth records diagnoses for extra payments within its Medicare Advantage plans, which cover over 7.8 million people.
- In addition, shares of other health insurers like Humana and CVS Health fell by 3% to 4% amid the increased scrutiny in the health insurance sector.
Bias Comparison
Bias Distribution
Left
Right
Untracked Bias
Medicare Advantage is a division of Medicare, the public health insurance program that serves more than 65 million elderly and disabled Americans. According to the U.S. Department of Health and Human Services (HHS), Medicare Advantage enrollees sat at roughly 25% in 2010. By 2024, that number had risen to 54%, according to the nonprofit health policy research firm KFF.
The investigation into UnitedHealthcare is being led by the DOJ’s civil fraud division and HHS’ inspector general’s office.

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.
Point phone camera here
According to the WSJ, the DOJ and HHS are looking into whether the healthcare conglomerate was billing the government based on inflated patient diagnoses, both inside and outside physician groups it owns. As of 2023, more than 90,000 physicians worked under UnitedHealthcare, representing nearly one in 10 U.S. doctors. The government pays private insurers a set rate to provide benefits to seniors beyond traditional Medicare coverage.
Some doctors have reportedly claimed that, through training and software, UnitedHealth encouraged them to document diagnoses that would result in higher profits for the company, regardless of whether those diagnoses were accurate or not.
In a statement, UnitedHealth Group, the parent company of UnitedHealthcare, accused the WSJ of reporting “misinformation” about its partnership with Medicare Advantage, adding that the company “consistently perform[s] at the industry’s highest levels” when reviewed by the government.
The statement goes on to say that the WSJ’s reporting amounts to a “year-long campaign to defend the legacy system that rewards volume over keeping patients healthy and addressing their underlying conditions,” calling the Journal’s allegations “outrageous and false.”
Get up to speed on the stories leading the day every weekday morning. Sign up for the newsletter today!
Learn more about our emails. Unsubscribe anytime.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
This DOJ investigation is just the latest in a series of scandals that have dogged UnitedHealth Group.
UnitedHealthcare was thrust into the spotlight in December after its CEO, Brian Thompson, was shot and killed while in New York to attend an annual UnitedHealth Group investors meeting. The company, which deals in health insurance, health technology, pharmacy benefits and physician practices, is one of the world’s largest corporations with a $457 billion market cap.
Also last year, a UnitedHealth Group technology company, Change Healthcare, suffered a data breach that exposed upwards of 85 million patient records. The company hosts roughly one-third of all payments made by insurers to providers.
More recently, CNBC reported that UnitedHealthcare is offering some employees in its benefits division a buyout option. If the company does not reach its workforce reduction goal through the buyouts –– which are available until March 3 –– it will begin laying off employees. UnitedHealth Group employed more than 440,00 people across its entire network of companies as of December 2023.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn moreBias Summary
- The U.S. Department of Justice has initiated a civil fraud investigation into UnitedHealth Group's Medicare billing practices, according to The Wall Street Journal.
- UnitedHealth Group's shares fell by 12% after the fraud investigation was reported.
- Physicians have indicated that UnitedHealth encouraged misleading diagnoses through training and software, raising concerns about the accuracy of medical billing.
- Doctors have claimed that UnitedHealth trained them to document profit-generating diagnoses, some of which were deemed questionable.
- No summary available because of a lack of coverage.
- The Department of Justice has started a civil fraud investigation into UnitedHealth's Medicare billing practices, according to the Wall Street Journal.
- UnitedHealth's shares dropped nearly 12% following the news, reflecting investor concerns about how the probe may affect profitability.
- The investigation focuses on how UnitedHealth records diagnoses for extra payments within its Medicare Advantage plans, which cover over 7.8 million people.
- In addition, shares of other health insurers like Humana and CVS Health fell by 3% to 4% amid the increased scrutiny in the health insurance sector.
Bias Comparison
Bias Distribution
Left
Right
Untracked Bias
Straight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
MOST POPULAR
-
AP Images
Pope Francis in critical condition with asthma-like respiratory crisis
Read5 hrs ago -
Getty Images
DOJ investigating UnitedHealth over Medicare Advantage billing: Report
Read8 hrs ago -
Reuters
Diddy’s defense attorney abruptly requests withdrawal from case
Watch 1:4021 hrs ago -
Getty Images
Judge allows CNN lawsuit potentially worth billions to continue
ReadYesterday